trial

Cerebellar Modulation of Cognition in Psychosis

NCTId NCT06107764
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Recruiting
Enrollment 95 (estimated)
Sponsored by Mclean Hospital
Primary completion 2029-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Recruiting
Enrollment
95 (estimated)
Study type
Interventional
Allocation
Randomized
Model
Crossover
Masking
Single
Start
2024-07-31
Primary completion
2029-12
Eligibility
ALL · 18 Years · 55 Years

Interventions & indications

Drugs
intermittant theta burst stimulation (iTBS)continuous theta burst stimulation (cTBS)

Sponsors

Mclean HospitalLead Sponsor
Beth Israel Deaconess Medical CenterCollaborator

Sites

2 total
Belmont, United StatesBoston, United States

Facts & assertions

4 sourced
Enrollment
95
Phase
NA
Primary Completion Date
2029-12
Status
RECRUITING
relationships
The graph out of here
drug
intermittant theta burst stimulation (iTBS)
drug
continuous theta burst stimulation (cTBS)
drug
lead_sponsor
Mclean Hospital
company
collaborator
Beth Israel Deaconess Medical Center
company
indication
Bipolar Disorder I
indication
Schizoaffective Disorder
indication
Psychosis
indication